Skip to main content
Fig. 4 | BMC Medical Genomics

Fig. 4

From: Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3–4 NSCLC patients

Fig. 4

The performance and distribution of PPS in IMvigor210 cohort. A Kaplan–Meier curve of patients in PPS-high and PPS-low groups. Log-rank test statistic was conducted to test statistical significance. B The PPS distribution of patients in treatment-benefit and treatment-non-benefit groups. Kruskal–Wallis statistic was conducted to test statistical significance. C The PPS distribution of patients in different immune phenotype groups. Kruskal–Wallis statistic was conducted to test statistical significance

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us